Table 1.
Baseline characteristics of the participants.
| Baseline Characteristics | Receiving β-Glucan (n = 23) |
Receiving Stratamed (n = 10) |
|---|---|---|
|
Age:
Median [Q1–Q3] |
47 (36–55) | 45 (41–53) |
|
Burn size
(cm2):
Median [Q1–Q3] |
108 (46.5–182) | 104.5 (21–144) |
|
Sex: n
(%)
Male Female |
13 (56.5) 10 (43.5) |
5 (50) 5 (50) |
|
Burn degree: n
(%)
Second-degree Second/third degree Third-degree |
12 (52.2) 3 (13.0) 8 (34.8) |
8 (80.0) 0 (0.0) 2 (20.0) |
|
Wound duration: n
(%)
<1 week 1–2 weeks 2 weeks >2 weeks |
2 (8.7) 9 (39.1) 8 (34.8) 4 (17.4) |
2 (20.0) 5 (50.0) 3 (30.0) 0 (0.0) |
|
Burn location: n
(%)
Arm and hand Leg and foot Others (head, neck, face, etc.) |
12 (52.2) 8 (34.8) 3 (13.0) |
7 (70.0) 3 (30.0) 0 (0.0) |
|
Ointment usage: n
(%)
1 week 2 weeks 3 weeks 4 weeks |
5 (21.7) 6 (26.1) 10 (43.5) 2 (8.7) |
4 (40.0) 6 (60.0) 0 (0.0) 0 (0.0) |